Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Kalil, Andre C.; Metersky, Mark L.; Klompas, Michael; Muscedere, John; Sweeney, Daniel A.; Palmer, Lucy B.; Napolitano, Lena M.; O'Grady, Naomi P.; Bartlett, John G.; Carratalà, Jordi; El Solh, Ali A.; Ewig, Santiago; Fey, Paul D.; File, Thomas M.; Restrepo, Marcos I.; Roberts, Jason A.; Waterer, Grant W.; Cruse, Peggy; Knight, Shandra L.; Brozek, Jan L.

doi:10.1093/cid/ciw353

Cited by 3,892Nosocomial Infections in ICUPneumonia and Respiratory InfectionsInfection Control in Healthcare

Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Open access

Kalil, Andre C., Metersky, Mark L., Klompas, Michael, Muscedere, John, Sweeney, Daniel A., Palmer, Lucy B., Napolitano, Lena M., O'Grady, Naomi P. +12 more·2016·Clinical Infectious Diseases

DOI 10.1093/cid/ciw353PMC PMC4981759

Open this paper in CoChat — free account Open PDF

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances. These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia. The panel's recommendations for the diagnosis and treatment of HAP and VAP are based upon evidence derived from topic-specific systematic literature reviews.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/cid/ciw353

Cites

363 of 363 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

In many RCTs of shorter versus longer antimicrobial courses for specific conditions, the shorter course was as effective as the longer course but associated with fewer adverse consequences.
“In many of the trials, the shorter course was just as effective as the longer course but associated with fewer adverse consequences.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [288]
Critically ill patients often receive antimicrobials for more days than necessary.
“however, critically ill patients often receive antimicrobials for more days than necessary [288, 301, 306].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [288]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435 · see citing works
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,870 · see citing works
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931 · see citing works
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724 · see citing works
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
Stevens, D. L., Bisno, A. L., Chambers, H. F. “., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,828 · see citing works
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772 · see citing works
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,195 · see citing works
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A. K., Patel, J. B., Srinivasan, A., Kallen, A. J., Limbago, B. M., Fridkin, S. K., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,593 · see citing works
Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
Stevens, D. L., Bisno, A. L., Chambers, H. F. “., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu444 · Cited by 1,525 · see citing works
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults: A Randomized Trial
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376 · see citing works
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 1× · see citing works
“TREM-1 is a member of the immunoglobulin superfamily that has been shown to be strongly expressed on the neutrophils and monocytes infiltrating tissues invaded by bacteria or fungi [107].”
Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial.
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183 · see citing works
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu027 · Cited by 1,090 · see citing works
Self-citation
Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions.
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046 · see citing works
Self-citation
Short-course Empiric Antibiotic Therapy for Patients with Pulmonary Infiltrates in the Intensive Care Unit
Singh, N., ROGERS, P., Atwood, C. W., Wagener, M. M., & Yu, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,020 · see citing works
Procalcitonin increase after endotoxin injection in normal subjects
Dandona, P., Nix, D. E., Wilson, M. F., Aljada, A., Love, J., Assicot, M., & Bohuon, C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989463 · Cited by 964 · see citing works
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948 · see citing works
Ventilator-associated Pneumonia Caused by Potentially Drug-resistant Bacteria
Trouillet, J., Chastre, J. E., Vuagnat, A., Joly‐Guillou, M., Combaux, D., Dombret, M.-C., & Gibert, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9705064 · Cited by 884 · see citing works
Pharmacokinetic issues for antibiotics in the critically ill patient
Roberts, J. A., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961bff · Cited by 861 · see citing works
Self-citation
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
Melsen, W. G., Rovers, M. M., Groenwold, R. H. H., Bergmans, D. C. J. J., Camus, C., Bauer, T. T., Hanisch, E. W., Klarin, B., Koeman, M., Krueger, W. A., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70081-1 · Cited by 856 · see citing works
Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia
Fagon, J.-Y., Chastre, J. E., Wolff, M., Gervais, C., Parer, S., Stéphan, F., Similowski, T., Mercat, A., Diehl, J., Sollet, J.-P., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00004 · Cited by 844 · see citing works
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 837 · see citing works
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Rybak, M. J., Lomaestro, B. M., Rotscahfer, J. C., Moellering, R. C., Craig, W. A., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · Clinical Infectious Diseases · doi:10.1086/600877 · Cited by 814 · see citing works
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 721 · see citing works
Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
Jones, R. N. (2010) · Clinical Infectious Diseases · doi:10.1086/653053 · Cited by 716 · see citing works
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schüetz, P., Wirz, Y., Sager, R., Christ‐Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J. E., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 701 · see citing works
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696 · see citing works
National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module
Dudeck, M. A., Weiner, L. M., Allen‐Bridson, K., Malpiedi, P. J., Peterson, K. D., Pollock, D. A., Sievert, D. M., & Edwards, J. R. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.09.002 · Cited by 657 · see citing works
Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia
Gibot, S., Cravoisy, A., Lévy, B., Béné, M. C., Faure, G. C., & Bollaert, P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031544 · Cited by 640 · see citing works
Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Colonization at Hospital Admission and Its Effect on Subsequent MRSA Infection
Davis, K. A., Stewart, J. J., Crouch, H. K., Florez, C. E., & Hospenthal, D. R. (2004) · Clinical Infectious Diseases · doi:10.1086/422997 · Cited by 607 · see citing works
Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -Lactamases
Paterson, D. L., Ko, W., von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mülazımoğlu, L., Trenholme, G. M., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571 · see citing works
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
Wunderink, R. G., Niederman, M. S., Kollef, M. H., Shorr, A. F., Kunkel, M. J., Baruch, A. M., McGee, W. T., Reisman, A. L., & Chastre, J. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir895 · Cited by 561 · see citing works
Vital signs: carbapenem-resistant Enterobacteriaceae.
(2013) · PubMed Central · Cited by 524 · see citing works
Linezolid versus Vancomycin for the Treatment of Methicillin‐Resistant Staphylococcus aureus Infections
Stevens, D. L., Herr, D., Lampiris, H. W., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/340353 · Cited by 512 · see citing works
The Influence of Mini-BAL Cultures on Patient Outcomes
Kollef, M. H., & Ward, S. (1998) · CHEST Journal · doi:10.1378/chest.113.2.412 · Cited by 498 · see citing works
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F. V., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 495 · see citing works
A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia
The Canadian Critical Care Trials Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052904 · Cited by 489 · see citing works
Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies
Fàbregas, N., Ewig, S., Torres, A., El-Ebiary, M., Ramírez, J., de la Bellacasa, J. P., Bauer, T. T., & Cabello, H. (1999) · Thorax · doi:10.1136/thx.54.10.867 · Cited by 486 · see citing works
Self-citation
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
Ibrahim, E. H., Ward, S., Sherman, G., Schaiff, R., Fraser, V. J., & Kollef, M. H. (2001) · Critical Care Medicine · doi:10.1097/00003246-200106000-00003 · Cited by 477 · see citing works
Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
Garnacho‐Montero, J., Ortíz-Leyba, C., Jimenez‐Jimenez, F. J., Barrero-Almodóvar, A., Garmendia, J. L. G., Bernabeu‐Wittel, M., Gallego‐Lara, S. L., & Madrazo-Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 469 · see citing works
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group
Fink, M. P., Snydman, D. R., Niederman, M. S., Leeper, K. V., Johnson, R. H., Heard, S. O., Wunderink, R. G., Caldwell, J. W., Schentag, J. J., & Siami, G. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.547 · Cited by 458 · see citing works
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
Kumar, A., Zarychanski, R., Light, B., Parrillo, J. E., Maki, D. G., Simon, D., Laporta, D. P., Lapinsky, S. E., Ellis, P., Mirzanejad, Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3ccd · Cited by 455 · see citing works
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
Klompas, M., Branson, R. D., Eichenwald, E. C., Greene, L. R., Howell, M. D., Lee, G. M., Magill, S. S., Maragakis, L. L., Priebe, G. P., Speck, K. A., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/677144 · Cited by 433 · see citing works
Self-citation
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05
Steinkraus, G. E., White, R. L., & Friedrich, L. V. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm258 · Cited by 420 · see citing works
Manual of Clinical Microbiology
Jorgensen, J. H., Pfaller, M. A., & Carroll, K. C. (2015) · ASM Press eBooks · doi:10.1128/9781555817381 · Cited by 420 · see citing works
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 419 · see citing works
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Durante‐Mangoni, E., Signoriello, G., Andini, R., Mattei, A., Cristoforo, M. D., Murino, P., Bassetti, M., Malacarne, P., Petrosillo, N., Galdieri, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit253 · Cited by 408 · see citing works
Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort
Kollef, M. H., Hamilton, C. W., & Ernst, F. R. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/664049 · Cited by 402 · see citing works
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
Paul, M., Lador, A., Grozinsky‐Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 388 · see citing works
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Nation, R. L., Li, J., Cars, O., Couet, W. R., Dudley, M. N., Kaye, K. S., Mouton, J. W., Paterson, D. L., Tam, V. H., Theuretzbacher, U., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70850-3 · Cited by 361 · see citing works
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial.
Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356 · see citing works
Physiology and genetics of procalcitonin.
Maruna, P., Nedĕlníková, K., & Gürlich, R. (2000) · PubMed · Cited by 355 · see citing works
Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients.
Chastre, J. E., Viau, F., Brun, P., Pierre, J., Dauge, M., Bouchama, A., Akesbi, A., & Gibert, C. (1984) · PubMed · doi:10.1164/arrd.1984.130.5.924 · Cited by 354 · see citing works
Variations in Etiology of Ventilator-associated Pneumonia across Four Treatment Sites: Implications for Antimicrobial Prescribing Practices
Rello, J., Borges-Sa, M., CORREA, H., LEAL, S.-R., & Baraibar, J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9812034 · Cited by 350 · see citing works
Impact of Invasive and Noninvasive Quantitative Culture Sampling on Outcome of Ventilator-Associated Pneumonia: A Pilot Study
Sánchez-Nieto, J. M., Torres, A., García-Córdoba, F., El-Ebiary, M., Carrillo, A., RUIZ, J., NUÑEZ, M. L., & Niederman, M. S. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.97-02039 · Cited by 344 · see citing works
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
Gales, A. C., Jones, R. N., & Sader, H. S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr239 · Cited by 341 · see citing works
Noninvasive Versus Invasive Microbial Investigation in Ventilator-associated Pneumonia
Ruiz, M., Torres, A., Ewig, S., Marcos, M. Á., Alcón, A., Lledó, R., Asenjo, M. A., & MALDONALDO, A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9907090 · Cited by 338 · see citing works
Self-citation
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals
Coffin, S. E., Klompas, M., Classen, D. C., Arias, K. M., Podgorny, K., Anderson, D. J., Burstin, H. R., Calfee, D. P., Dubberke, E. R., Fraser, V. J., et al. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/591062 · Cited by 337 · see citing works
Self-citation
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
Kumar, A., Safdar, N., Kethireddy, S., & Chateau, D. G. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e96b91 · Cited by 335 · see citing works
Diagnostic Tests for Pneumonia in Ventilated Patients: Prospective Evaluation of Diagnostic Accuracy Using Histology as a Diagnostic Gold Standard
Marquette, C., Copin, M., Wallet, F., et al. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.6.7767535 · Cited by 335 · see citing works
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
Jeffres, M. N., Isakow, W., Doherty, J. A., Micek, S. T., & Kollef, M. H. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.06.014 · Cited by 333 · see citing works
Bacterial Colonization Patterns in Mechanically Ventilated Patients with Traumatic and Medical Head Injury: Incidence, Risk Factors, and Association with Ventilator-associated Pneumonia
Ewig, S., Torres, A., El-Ebiary, M., Fàbregas, N., Hernández, C., González, J., Nicolas, J. M., & Soto, L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803097 · Cited by 332 · see citing works
Self-citation
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
Stolz, D., Smyrnios, N., Eggimann, P., Pargger, H., Thakkar, N., Siegemund, M., Marsch, S., Azzola, A., Rakic, J., Mueller, B., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00053209 · Cited by 327 · see citing works
Bronchoscopic or Blind Sampling Techniques for the Diagnosis of Ventilator-Associated Pneumonia
Papazian, L., Thomas, P. A., Garbe, L., Guignon, I., Thirion, X., Charrel, J., Claude Bollet, C., Fuentes, P., & Gouin, F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520766 · Cited by 326 · see citing works
Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia
Kollef, M. H., Morrow, L. E., Niederman, M. S., Leeper, K. V., Anzueto, A., Scott, L. B., & Rodino, F. J. (2006) · CHEST Journal · doi:10.1378/chest.129.5.1210 · Cited by 322 · see citing works
Diagnosing Pneumonia during Mechanical Ventilation
Fartoukh, M. S., Maître, B., Honoré, S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200212-1449oc · Cited by 319 · see citing works
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
Chung, D. R., Song, J., Ys, K., Thamlikitkul, V., Huang, S.-G., Wang, H., So, T. M.-K., Yasin, R. M., Hsueh, P., Carlos, C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0349oc · Cited by 309 · see citing works
A Randomized Controlled Trial of an Antibiotic Discontinuation Policy for Clinically Suspected Ventilator-Associated Pneumonia
Micek, S. T., Ward, S., Fraser, V. J., & Kollef, M. H. (2004) · CHEST Journal · doi:10.1378/chest.125.5.1791 · Cited by 306 · see citing works
Validation of Different Techniques for the Diagnosis of Ventilator-Associated Pneumonia. Comparison with Immediate Postmortem Pulmonary Biopsy
Torres, A., El-Ebiary, M., Massaguer, L. P., González, J., de la Bellacasa, J. P., Ramírez, J., Xaubet, A., Ferrer, M., & Rodriguez‐Roisin, R. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306025 · Cited by 300 · see citing works
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Armand-Lefèvre, L., Angebault, C., Barbier, F., Hamelet, E., Defrance, G., Ruppé, É., Bronchard, R., Lepeule, R., Lucet, J., Mniai, A. E., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01823-12 · Cited by 299 · see citing works
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
Pugh, R., Grant, C., Cooke, R. P., & Dempsey, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007577.pub3 · Cited by 289 · see citing works
A Comparative Analysis of Patients With Early-Onset vs Late-Onset Nosocomial Pneumonia in the ICU Setting
Ibrahim, E., Ward, S., Sherman, G., & Kollef, M. H. (2000) · CHEST Journal · doi:10.1378/chest.117.5.1434 · Cited by 284 · see citing works
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*
Garnacho‐Montero, J., Borges-Sa, M., Solé‐Violán, J., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000275389.31974.22 · Cited by 282 · see citing works
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Freire, A., Melnyk, V. P., Kim, M. J., Datsenko, O., Dzyublik, O. Y., Глумчер, Ф. С., Chuang, Y.-C., Maroko, R. T., Dukart, G., Cooper, C. A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.05.012 · Cited by 282 · see citing works
A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia
Barker, J. A. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79233-2 · Cited by 282 · see citing works
Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis
Schüetz, P., Briel, M., Christ‐Crain, M., Stolz, D., Bouadma, L., Wolff, M., Luyt, C. E., Chastre, J. E., Tubach, F., Kristoffersen, K. B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis464 · Cited by 280 · see citing works
A Prospective Cooperative Study of Complications following Flexible Fiberoptic Bronchoscopy
Pereira, W., Kovnat, D. M., & Snider, G. L. (1978) · CHEST Journal · doi:10.1378/chest.73.6.813 · Cited by 276 · see citing works
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schüetz, P., Müller-Stich, B. P., Christ‐Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J. E., Tubach, F., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub2 · Cited by 267 · see citing works
The Diagnosis of Ventilator-Associated Pneumonia
Kirtland, S. H., Corley, D. E., Winterbauer, R. H., et al. (1997) · CHEST Journal · doi:10.1378/chest.112.2.445 · Cited by 258 · see citing works
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit*
Palmer, L. B., Smaldone, G. C., Chen, J. J.-W., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817c0f9e · Cited by 258 · see citing works
Self-citation
Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia
Müller, F., Christ‐Crain, M., Bregenzer, T., Krause, M., Zimmerli, W., Müeller, B., & Schüetz, P. (2010) · CHEST Journal · doi:10.1378/chest.09-2920 · Cited by 256 · see citing works
National Trends in Patient Safety for Four Common Conditions, 2005–2011
Wang, Y., Eldridge, N., Metersky, M. L., Verzier, N. R., Meehan, T. P., Pandolfi, M. M., Foody, J. M., Ho, S., Galusha, D. H., Kliman, R. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmsa1300991 · Cited by 252 · see citing works
Self-citation
Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis
Chalmers, J. D., Rother, C., Salih, W., & Ewig, S. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit734 · Cited by 250 · see citing works
Self-citation
Nosocomial pneumonia in patients with acute respiratory distress syndrome
CHASTRE, J., TROUILLET, J. L., VUAGNAT, A., JOLY-GUILLOU, M. L., CLAVIER, H., DOMBRET, M. C., & GIBERT, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9708057 · Cited by 250 · see citing works
Postoperative Pneumonia after Major Lung Resection
Schussler, O., Alifano, M., Dermine, H., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1556oc · Cited by 248 · see citing works
De-escalation therapy in ventilator-associated pneumonia*
Rello, J., Vidaur, L., Sandiumenge, A., Rodríguez, A. H., Gualis, B., Boqué, C., & Dı́az, E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145997.10438.28 · Cited by 248 · see citing works
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
Luna, C. M., Aruj, P. K., Niederman, M. S., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.06.00049105 · Cited by 248 · see citing works
Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
Rubinstein, E., Lalani, T., Corey, G. R., Kanafani, Z. A., Nannini, E. C., ROCHA, M. G. G. D., Rahav, G., Niederman, M. S., Kollef, M. H., Shorr, A. F., et al. (2010) · Clinical Infectious Diseases · doi:10.1093/cid/ciq031 · Cited by 247 · see citing works
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial.
Leone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3411-8 · Cited by 243 · see citing works
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*
Chastre, J. E., Wunderink, R. G., Prokocimer, P., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181691b99 · Cited by 237 · see citing works
Colistin vs . the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
Aydemir, H., Akduman, D., Pişkin, N., Cömert, F., HORUZ, E., TERZI, A., Köktürk, F., Örnek, T., & Çelebi, G. (2012) · Epidemiology and Infection · doi:10.1017/s095026881200194x · Cited by 237 · see citing works
Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator‐Associated Pneumonia and Hospital‐Acquired Pneumonia
Muscedere, J., Day, A. G., & Heyland, D. K. (2010) · Clinical Infectious Diseases · doi:10.1086/653060 · Cited by 232 · see citing works
Self-citation
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
Awad, S. S., Rodríguez, A. H., Chuang, Y.-C., Marjanek, Z., Pareigis, A. J., Reis, G., Scheeren, T., Sanchez, A. S., Zhou, X., Saulay, M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu219 · Cited by 232 · see citing works
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Betrosian, A. P., Frantzeskaki, F. G., Xanthaki, A., et al. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.002 · Cited by 230 · see citing works
Multicenter Prospective Study of Ventilator-Associated Pneumonia During Acute Respiratory Distress Syndrome: Incidence, Prognosis, and Risk Factors
Markowicz, P., Wolff, M., Djedaïni, K., Cohen, Y., Chastre, J. E., Delclaux, C., Merrer, J., HERMAN, B., Veber, B., FONTAINE, A., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9909122 · Cited by 229 · see citing works
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O’Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Gao, W., Christiansen, K. J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir270 · Cited by 228 · see citing works
Vancomycin dosing in critically ill patients: Robust methods for improved continuous-infusion regimens.
Roberts, J. A., Taccone, F. S., Udy, A. A., Vincent, J.-L., Jacobs, F., & Lipman, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01708-10 · Cited by 226 · see citing works
Self-citation
Multicenter Study of Hospital-Acquired Pneumonia in Non-ICU Patients
Sopena, N., & Sabrià, M. (2005) · CHEST Journal · doi:10.1378/chest.127.1.213 · Cited by 222 · see citing works
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.
Mendelman, P. M., Smith, A. L., Lévy, J., et al. (1985) · PubMed · doi:10.1164/arrd.1985.132.4.761 · Cited by 217 · see citing works
Treatment of Gram-positive Nosocomial Pneumonia: Prospective Randomized Comparison of Quinupristin/Dalfopristin versus Vancomycin
Fagon, J.-Y., Patrick, H., Haas, D. W., Torres, A., Gibert, C., Cheadle, W. G., Falcone, R. E., Anholm, J. D., Paganin, F., Fabian, T. C., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9904115 · Cited by 214 · see citing works
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Rattanaumpawan, P., Lorsutthitham, J., Ungprasert, P., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq360 · Cited by 212 · see citing works
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
Kollef, M. H., Chastre, J. E., Clavel, M., Restrepo, M. I., Michiels, B., Kaniga, K., Cirillo, I., Kimko, H. H. C., & Redman, R. L. (2012) · Critical Care · doi:10.1186/cc11862 · Cited by 208 · see citing works
Self-citation
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia
Berton, D. C., Kalil, A. C., & Teixeira, P. J. Z. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006482.pub4 · Cited by 208 · see citing works
Self-citation
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study
Kofteridis, D. P., Alexopoulou, C., Valachis, A., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/657242 · Cited by 207 · see citing works
Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study
Martín‐Loeches, I., Póvoa, P. M. S. R., Rodríguez, A. H., Curcio, D., Suarez, D. L., Mira, J. P., Cordero, M., Lepecq, R., Girault, C., Candeias, C., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00326-4 · Cited by 207 · see citing works
Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome
Nseir, S., Pompéo, C. D., Pronnier, P., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00012902 · Cited by 206 · see citing works
Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia
Violán, J. S., Fernandez, J., Benítez, A. B., et al. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00009 · Cited by 206 · see citing works
Nosocomial Pneumonia
Höffken, G., & Niederman, M. S. (2002) · CHEST Journal · doi:10.1378/chest.122.6.2183 · Cited by 204 · see citing works
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia*
Heyland, D. K., Dodek, P., Muscedere, J., Day, A. G., & Cook, D. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0b013e31816203d6 · Cited by 201 · see citing works
Self-citation
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
Cometta, A., Baumgartner, J. D., Lew, D., Zimmerli, W., Pittet, D., Chopart, P., Schaad, U. B., Herter, C., Eggimann, P., & Huber, O. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1309 · Cited by 199 · see citing works
Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study
Zanetti, G. M. R., Bally, F., Greub, G., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3442-3447.2003 · Cited by 198 · see citing works
Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis
Kuti, E. L., Patel, A. A., & Coleman, C. I. (2008) · Journal of Critical Care · doi:10.1016/j.jcrc.2007.08.007 · Cited by 198 · see citing works
Epidemiology of Ventilator-acquired Pneumonia Based on Protected Bronchoscopic Sampling
George, D. L., Falk, P. S., Wunderink, R. G., Leeper, K. V., Meduri, G. U., Steere, E. L., Corbett, C., & Mayhall, C. G. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9610069 · Cited by 196 · see citing works
Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated Patients
Esperatti, M., Ferrer, M., Theessen, A., Liapikou, A., Valencia, M., Saucedo, L. M., Zavala, E., Welte, T., & Torres, A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0094oc · Cited by 194 · see citing works
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
Klompas, M., Branson, R. D., Eichenwald, E. C., Greene, L. R., Howell, M. D., Lee, G. M., Magill, S. S., Maragakis, L. L., Priebe, G. P., Speck, K. A., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1017/s0899823x00193894 · Cited by 194 · see citing works
Self-citation
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Μάρκου, Ν., Markantonis, S. L., Dimitrakis, E., et al. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.01.015 · Cited by 192 · see citing works
Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria
Tumbarello, M., PASCALE, G. D., Trecarichi, E. M., et al. (2013) · CHEST Journal · doi:10.1378/chest.13-1018 · Cited by 190 · see citing works
Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria
Ouderkirk, J. P., Nord, J. A., Turett, G. S., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2659-2662.2003 · Cited by 190 · see citing works
Early onset pneumonia: a multicenter study in intensive care units
Langer, M., Cigada, M., Mandelli, M., et al. (1987) · Intensive Care Medicine · doi:10.1007/bf00255791 · Cited by 187 · see citing works
Microbiology of Ventilator–Associated Pneumonia Compared With That of Hospital-Acquired Pneumonia
Weber, D. J., Rutala, W. A., Sickbert-Bennett, E. E., Samsa, G. P., Brown, V., & Niederman, M. S. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518460 · Cited by 185 · see citing works
Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia
Dangerfield, B. S., Chung, A. S., Webb, B. J., & Seville, M. T. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01805-13 · Cited by 183 · see citing works
Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study
Nseir, S., Favory, R., Jozefowicz, E., et al. (2008) · Critical Care · doi:10.1186/cc6890 · Cited by 181 · see citing works
Prevalence and Risk Factors for Acquisition of Carbapenem-Resistant Enterobacteriaceae in the Setting of Endemicity
Swaminathan, M., Sharma, S., Blash, S., Patel, G., Banach, D. B., Phillips, M., LaBombardi, V. J., Anderson, K. F., Kitchel, B., Srinivasan, A., et al. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/671270 · Cited by 179 · see citing works
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
Korbila, I. P., Michalopoulos, A. S., Rafailidis, P. I., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03040.x · Cited by 172 · see citing works
Association Between Vancomycin Minimum Inhibitory Concentration and Mortality Among Patients WithStaphylococcus aureusBloodstream Infections
Kalil, A. C., Schooneveld, T. C. V., Fey, P. D., & Rupp, M. E. (2014) · JAMA · doi:10.1001/jama.2014.6364 · Cited by 170 · see citing works
Self-citation
Toward Improved Surveillance: The Impact of Ventilator-Associated Complications on Length of Stay and Antibiotic Use in Patients in Intensive Care Units
Hayashi, Y., Morisawa, K., Klompas, M., Jones, M., Bandeshe, H., Boots, R. J., Lipman, J., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis926 · Cited by 168 · see citing works
Self-citation
Implementation of Bronchoscopic Techniques in the Diagnosis of Ventilator-associated Pneumonia to Reduce Antibiotic Use
Bonten, M. J. M., Bergmans, D. C. J. J., Stobberingh, E. E., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9610117 · Cited by 166 · see citing works
Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
Peña, C., Suarez, C., Ocampo-Sosa, A. A., Murillas, J., Almirante, B., Pomar, V., Aguilar, M., Granados, A., Calbo, E., Rodríguez‐Baño, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit223 · Cited by 165 · see citing works
The Clinical Utility of Invasive Diagnostic Techniques in the Setting of Ventilator-Associated Pneumonia
Heyland, D. K., Cook, D. J., Marshall, J. C., et al. (1999) · CHEST Journal · doi:10.1378/chest.115.4.1076 · Cited by 163 · see citing works
Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
Morata, L., Cobos-Trigueros, N., Martínez, J. A., Soriano, À., Almela, M., Marco, F., Sterzik, H., Núñez, R., Hernández, C., & Mensa, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00750-12 · Cited by 162 · see citing works
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
Nicolau, D. P., McNabb, J., Lacy, M. K., Quintiliani, R., & Nightingale, C. H. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00329-6 · Cited by 161 · see citing works
Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia
Luyt, C. E., Combes, A., Reynaud, C., Hékimian, G., Nieszkowska, A., Tonnellier, M., Aubry, A., Trouillet, J., Bernard, M., & Chastre, J. E. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1112-x · Cited by 160 · see citing works
Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled Trial
Sakka, S. G., Glauner, A. K., Bulitta, J. B., Kinzig‐Schippers, M., Pfister, W., Drusano, G. L., & Sörgel, F. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01318-06 · Cited by 159 · see citing works
Prospective Randomized Comparison of Imipenem-Cilastatin and Piperacillin-Tazobactam in Nosocomial Pneumonia or Peritonitis
Jaccard, C., Troillet, N., Harbarth, S., Zanetti, G. M. R., Aymon, D., Schneider, R., Chioléro, R., Ricou, B., Romand, J., Huber, O., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2966 · Cited by 159 · see citing works
Comparison of Ampicillin‐Sulbactam and Imipenem‐Cilastatin for the Treatment ofAcinetobacterVentilator‐Associated Pneumonia
Wood, G. C., Hanes, S. D., Croce, M. A., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 157 · see citing works
Reduction of Bacterial Resistance with Inhaled Antibiotics in the Intensive Care Unit
Palmer, L. B., & Smaldone, G. C. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2161oc · Cited by 154 · see citing works
Self-citation
National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module
Dudeck, M. A., Horan, T. C., Peterson, K. D., Allen‐Bridson, K., Morrell, G. C., Pollock, D. A., & Edwards, J. R. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.04.011 · Cited by 154 · see citing works
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
Sobieszczyk, M. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh369 · Cited by 153 · see citing works
Penetration of Gentamicin Into the Alveolar Lining Fluid of Critically Ill Patients With Ventilator-Associated Pneumonia
Panidis, D., Markantonis, S. L., Boutzouka, E. G., Karatzas, S., & Baltopoulos, G. I. (2005) · CHEST Journal · doi:10.1378/chest.128.2.545 · Cited by 153 · see citing works
Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: Prevalence, incidence, risk factors, and outcomes
Parker, C. M., Kutsogiannis, J., Muscedere, J., Cook, D., Dodek, P., Day, A. G., & Heyland, D. K. (2008) · Journal of Critical Care · doi:10.1016/j.jcrc.2008.02.001 · Cited by 150 · see citing works
Self-citation
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
Florescu, D. F., Qiu, F., McCartan, M. A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir934 · Cited by 150 · see citing works
Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
Pakyz, A. L., Oinonen, M. J., & Polk, R. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01535-08 · Cited by 150 · see citing works
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia
Dimοpoulos, G., Poulakou, G., Pneumatikos, I. A., Armaganidis, A., Kollef, M. H., & Matthaiou, D. K. (2013) · CHEST Journal · doi:10.1378/chest.13-0076 · Cited by 147 · see citing works
Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors
Martín‐Loeches, I., Deja, M., Koulenti, D., Dimοpoulos, G., Marsh, B. J., Torres, A., Niederman, M. S., Rello, J., & EU-VAP Study Investigators (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2808-5 · Cited by 144 · see citing works
Alveolar and Serum Procalcitonin
Duflo, F., Debon, R., Monneret, G., et al. (2002) · Anesthesiology · doi:10.1097/00000542-200201000-00018 · Cited by 143 · see citing works
Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia
Determann, R. M., Millo, J. L., Gibot, S., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2818-7 · Cited by 143 · see citing works
Using Local Microbiologic Data To Develop Institution-Specific Guidelines for the Treatment of Hospital-Acquired Pneumonia
Beardsley, J. R., Williamson, J., Johnson, J. W., Ohl, C. A., Karchmer, T. B., & Bowton, D. L. (2006) · CHEST Journal · doi:10.1378/chest.130.3.787 · Cited by 140 · see citing works
Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia
Gross, A. E., Schooneveld, T. C. V., Olsen, K. M., Rupp, M. E., Bui, T. H., Forsung, E., & Kalil, A. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02582-14 · Cited by 139 · see citing works
Self-citation
Blood Cultures Have Limited Value in Predicting Severity of Illness and as a Diagnostic Tool in Ventilator-Associated Pneumonia
Luna, C. M., Videla, A. J., Mattera, J., Vay, C. A., Famiglietti, A. M. R., Vujacich, P., & Niederman, M. S. (1999) · CHEST Journal · doi:10.1378/chest.116.4.1075 · Cited by 135 · see citing works
Utility of Gram's Stain and Efficacy of Quantitative Cultures for Posttraumatic Pneumonia
Croce, M. A., Fabian, T. C., Waddle-Smith, L., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199805000-00015 · Cited by 134 · see citing works
High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii
Betrosian, A. P., Frantzeskaki, F. G., Xanthaki, A., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600951184 · Cited by 133 · see citing works
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Ramírez, P., Garcia, M., Ferrer, M., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00086707 · Cited by 130 · see citing works
Pseudomonas aeruginosa Ventilator-associated Pneumonia. Predictive Factors of Treatment Failure
Planquette, B., Timsit, J., Misset, B., Schwebel, C., Azoulay, É., Adrie, C., Vesin, A., Jamali, S., Zahar, J., Allaouchiche, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1897oc · Cited by 129 · see citing works
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
Álvarez-Lerma, F., Álvarez, B., Luque, P., et al. (2006) · Critical Care · doi:10.1186/cc4919 · Cited by 128 · see citing works
Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections
Liscio, J. L., Mahoney, M. V. G., & Hirsch, E. B. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.05.003 · Cited by 128 · see citing works
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment
Capellier, G., Mockly-Postal, H., Charpentier, C., Annane, D., Blasco, G., Desmettre, T., Roch, A., Faisy, C., Cousson, J., Limat, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041290 · Cited by 128 · see citing works
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
Lorente, L., Jiménez, A., Martin, M. M. I. D. O., Iribarren, J. L., Jiménez, J. J., & Mora, M. L. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.025 · Cited by 127 · see citing works
Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis
Chuang, Y., Cheng, C., Sheng, W., Sun, H., Wang, J., Chen, Y., & Chang, S. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-102 · Cited by 125 · see citing works
Recent Exposure to Antimicrobials and Carbapenem-Resistant Enterobacteriaceae: The Role of Antimicrobial Stewardship
Marchaim, D., Chopra, T., Bhargava, A., Bogan, C., Dhar, S., Hayakawa, K., Pogue, J. M., Bheemreddy, S., Blunden, C. E., Shango, M. M., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/666642 · Cited by 125 · see citing works
Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin
SIEGER, B. E., Berman, S., Geckler, R. W., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199710000-00015 · Cited by 124 · see citing works
Rising Rates of Carbapenem-Resistant Enterobacteriaceae in Community Hospitals: A Mixed-Methods Review of Epidemiology and Microbiology Practices in a Network of Community Hospitals in the Southeastern United States
Thaden, J. T., Lewis, S. S., Hazen, K. C., Huslage, K., Fowler, V. G., Moehring, R. W., Chen, L. F., Jones, C. D., Moore, Z., Sexton, D. J., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/677157 · Cited by 123 · see citing works
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan
KOHNO, S., Yamaguchi, K., Aikawa, N., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm369 · Cited by 122 · see citing works
Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006
Sader, H. S., Fey, P. D., Fish, D. N., Limaye, A. P., Pankey, G. A., Rahal, J. J., Rybak, M. J., Snydman, D. R., Steed, L. L., Waites, K. B., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00616-09 · Cited by 121 · see citing works
Self-citation
Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials
Aarts, M.-A. W., Hancock, J., Heyland, D. K., et al. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000297956.27474.9d · Cited by 120 · see citing works
Intermittent and continuous ceftazidime infusion for critically ill trauma patients
Hanes, S. D., Wood, G. C., Herring, V. L., Croce, M. A., Fabian, T. C., Pritchard, E., & Boucher, B. A. (2000) · The American Journal of Surgery · doi:10.1016/s0002-9610(00)00388-3 · Cited by 119 · see citing works
Comparison of the Bacterial Etiology of Early-Onset and Late-Onset Ventilator-Associated Pneumonia in Subjects Enrolled in 2 Large Clinical Studies
Restrepo, M. I., Peterson, J., Fernandez, J. F., Qin, Z., Fisher, A. C., & Nicholson, S. (2013) · Respiratory Care · doi:10.4187/respcare.02173 · Cited by 118 · see citing works
Self-citation
Linezolid vs Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
Walkey, A. J., O’Donnell, M. R., & Wiener, R. S. (2010) · CHEST Journal · doi:10.1378/chest.10-1556 · Cited by 117 · see citing works
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis*
Kalil, A. C., Murthy, M. H., Hermsen, E. D., Neto, F. K., Sun, J., & Rupp, M. E. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3b96 · Cited by 116 · see citing works
Self-citation
β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis
Vardakas, K. Z., Tansarli, G. S., Bliziotis, I. A., & Falagas, M. E. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.006 · Cited by 115 · see citing works
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
Paul, M., Grozinsky‐Glasberg, S., Soares‐Weiser, K., & Leibovici, L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub2 · Cited by 114 · see citing works
Incidence and Susceptibility of Pathogenic Bacteria Vary between Intensive Care Units within a Single Hospital: Implications for Empiric Antibiotic Strategies
Namias, N., Samiian, L., Niño, D. F., et al. (2000) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200010000-00010 · Cited by 113 · see citing works
Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled Trial
Brun‐Buisson, C., Sollet, J.-P., Schweich, H., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516294 · Cited by 113 · see citing works
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study
Cepeda, J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh048 · Cited by 113 · see citing works
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study
Réa-Neto, Á., Niederman, M. S., Lobo, S. M., Schroeder, E., Lee, M., Kaniga, K., Ketter, N., Prokocimer, P., & Friedland, I. R. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802179255 · Cited by 112 · see citing works
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
Montedori, A., Bonacini, I., Casazza, G., Luchetta, M. L., Duca, P., Cozzolino, F., & Abraha, I. (2011) · Trials · doi:10.1186/1745-6215-12-58 · Cited by 112 · see citing works
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh088 · Cited by 112 · see citing works
Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae
Balakrishnan, I., Awad-El-Kariem, F. M., Aali, A., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr317 · Cited by 111 · see citing works
Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria
Giantsou, E., Liratzopoulos, N., Efraimidou, E., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2697-y · Cited by 110 · see citing works
Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia*
Agbaht, K., Diaz, E., Muñoz, E., Lisboa, T., Gomez, F., Depuydt, P. O., Blot, S. I., & Rello, J. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000277042.31524.66 · Cited by 109 · see citing works
Antimicrobial Resistance Prevalence Rates in Hospital Antibiograms Reflect Prevalence Rates among Pathogens Associated with Hospital‐Acquired Infections
Fridkin, S. K., Edwards, J. R., Tenover, F. C., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321893 · Cited by 107 · see citing works
Does De-Escalation of Antibiotic Therapy for Ventilator-Associated Pneumonia Affect the Likelihood of Recurrent Pneumonia or Mortality in Critically Ill Surgical Patients?
Eachempati, S. R., Hydo, L. J., Shou, J., et al. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31819dca4e · Cited by 105 · see citing works
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study
West, M., Boulanger, B. R., Fogarty, C. M., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80091-7 · Cited by 104 · see citing works
Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline
Bhavnani, S. M., Rubino, C. M., Hammel, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01615-10 · Cited by 103 · see citing works
Antibiotic Utilization and Outcomes for Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative BAL Culture Results
Kollef, M. H., & Kollef, K. E. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2706 · Cited by 103 · see citing works
Diagnosis of ventilator-associated pneumonia
Grgurich, P. E., Hudcova, J., Lei, Y., Sarwar, A., & Craven, D. E. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32835ebbd0 · Cited by 102 · see citing works
Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
Joung, M. K., Lee, J.-A., Moon, S., et al. (2011) · Critical Care · doi:10.1186/cc10072 · Cited by 101 · see citing works
Early Microbiological Response to Linezolid vs Vancomycin in Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Wunderink, R. G., Mendelson, M. H., Somero, M. S., et al. (2008) · CHEST Journal · doi:10.1378/chest.08-0011 · Cited by 101 · see citing works
Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Furtado, G. H. C., d’Azevedo, P. A., Santos, A. F., et al. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.017 · Cited by 100 · see citing works
De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate
Giantsou, E., Liratzopoulos, N., Efraimidou, E., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0619-x · Cited by 100 · see citing works
Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia
DeRyke, C. A., Lodise, T. P., Rybak, M. J., & McKinnon, P. S. (2005) · CHEST Journal · doi:10.1378/chest.128.3.1414 · Cited by 100 · see citing works
Diagnostic Accuracy of Clinical Pulmonary Infection Score for Ventilator-Associated Pneumonia: A Meta-analysis
Shan, J., Chen, H., & Zhu, J. (2011) · Respiratory Care · doi:10.4187/respcare.01097 · Cited by 100 · see citing works
Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Kalın, G., Alp, E., Akin, A., et al. (2013) · Infection · doi:10.1007/s15010-013-0495-y · Cited by 98 · see citing works
Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group
Brown, R. B., Kruse, J. A., Counts, G. W., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.269 · Cited by 97 · see citing works
Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: Results of the Eole study
Montravers, P., Veber, B., Auboyer, C., Dupont, H., Gauzit, R., Korinek, A. M., Mallédant, Y., Martin, C., Moine, P., & Pourriat, J. L. (2002) · Critical Care Medicine · doi:10.1097/00003246-200202000-00017 · Cited by 97 · see citing works
Decision Making in Nosocomial Pneumonia
Baker, A. M., Bowton, D. L., & Haponik, E. F. (1995) · CHEST Journal · doi:10.1378/chest.107.1.85 · Cited by 95 · see citing works
Ventilator-Associated Tracheobronchitis in a Mixed Surgical and Medical ICU Population
Dallas, J., Skrupky, L. P., Abebe, N., et al. (2010) · CHEST Journal · doi:10.1378/chest.10-1336 · Cited by 95 · see citing works
Quantifying the Impact of Extranasal Testing of Body Sites for Methicillin-ResistantStaphylococcus aureusColonization at the Time of Hospital or Intensive Care Unit Admission
McKinnell, J. A., Huang, S. S., Eells, S. J., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/669095 · Cited by 94 · see citing works
Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: A meta-analysis of retrospective and prospective studies
Hu, Y., Li, L., Li, W., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.002 · Cited by 94 · see citing works
Is the Gram Stain Useful in the Microbiologic Diagnosis of VAP? A Meta-analysis
O’Horo, J. C., Thompson, D., & Safdar, N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis512 · Cited by 94 · see citing works

Flagged first, then by citations

Research works printed but not linked: 14

[25]25. Gastmeier P, Sohr D, Geffers C, Ruden H, Vonberg RP, Welte T. Early- and lateonset pneumonia: is this still a useful classi fi cation? Antimicrob Agents Chemother 2009 ; 53:2714 -8.
[65]65. Kirtland SH, Corley DE, Winterbauer RH, et al. The diagnosis of ventilatorassociated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997 ; 112:445 -57.
[166]166. Thomas PD, Daly S, Misan G, Steele T. Comparison of the ef fi cacy and adverse effect pro fi le of cefotaxime, 3 g/day, and ceftriaxone, 2 g/day, in the treatment of nosocomial lower respiratory tract infections in ICU patients. Eur Respir Rev 1994 ; 4:321 -8.
[175]175. Beaucaire G, Nicolas MH, Martin C, et al. Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study [in French]. Ann Fr Anesth Reanim 1999 ; 18:186 -95.
[181]181. Brown RB, Lemeshow S, Teres D. Moxalactam vs carbenicillin plus tobramycin: treatment of nosocomial gram-negative bacillary pneumonias in non-neutropenic patients. Curr Ther Res 1984 ; 36:557 -64.
[211]211. Jacob J, Klein E, Laxminarayan R, et al. Carbapenem resistant enterobactereciae. MMWR Morb Mortal Wkly Rep 2013 ; 62:165 -70.
[215]215. Alsuraikh M, Hamdy G. Incidence, risk factors, and causative agents of hospital acquired pneumonia (nosocomial pneumonia) in adult hospitalized patients in medical wards of a general hospital in Kuwait. Kuwait Med J 2008 ; 40:297 -300.
[224]224. Barreiro-Lopez B, Tricas JM, Mauri E, Quintana S, Garau J. Risk factors and prognostic factors in nosocomial pneumonia outside the intensive care units setting [in Spanish]. Enferm Infecc Microbiol Clin 2005 ; 23:519 -24.
[238]238. Pea F, Di Qual E, Cusenza A, Brollo L, Baldassarre M, Furlanut M. Pharmacokinetics and pharmacodynamics of intravenous levo fl oxacin in patients with earlyonset ventilator-associated pneumonia. Clin Pharmacokinet 2003 ; 42:589 -98.
[263]263. Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and ef fi cacy in cystic fi brosis sputum. Am Rev Respir Dis 1985 ; 132:761 -5.
[346]346. Fekih Hassen M, Ayed S, Ben Sik Ali H, Gharbi R, Marghli S, Elatrous S. Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study [in French]. Ann Fr Anesth Reanim 2009 ; 28:16 -23.
[347]347. Medina J, Perez Protto S, Paciel D, Pontet J, Saldun P, Berro M. Antibiotic treatment for the ventilator-associated pneumonia: 8 vs. 12 days randomized trial preliminary data. In: Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2007 :361.
[355]355. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a deescalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002 ; 122:2183 -96.
[363]363. Pontet J, Paciel D, Olivera W, Bentancourt S, Cancela M, Gervas J. Procalcitonin (PCT) guided antibiotic treatment in ventilator associated pneumonia (VAP). Multi-centre, clinical prospective, randomized-controlled study. Am J Respir Crit Care Med 2007 ; 175:A212.

Sorted by citations

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621 · see citing works
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652 · see citing works
Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657 · see citing works
Self-citation
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935 · see citing works
Self-citation
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT)
Torres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00582-2017 · Cited by 1,387 · see citing works
Self-citation
Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections.
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740 · see citing works
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641 · see citing works
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
Langelier, C., Kalantar, K. L., Moazed, F., Wilson, M. R., Crawford, E. D., Deiss, T., Belzer, A., Bolourchi, S., Caldera, S., Fung, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809700115 · Cited by 411 · see citing works
Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use.
Rhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., Klompas, M., & Program, F. T. C. P. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2899 · Cited by 397 · see citing works
Self-citation
Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: A systematic review and meta-analysis of randomised trials.
Vardakas, K. Z., Voulgaris, G. L., Maliaros, A., Samonis, G., & Falagas, M. E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30615-1 · Cited by 327 · see citing works
Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia: A Multihospital Cohort Study
Vaughn, V. M., Flanders, S. A., Snyder, A., Conlon, A., Rogers, M. A. M., Malani, A. N., McLaughlin, E., Bloemers, S., Srinivasan, A., Nagel, J., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3640 · Cited by 247 · see citing works
Duration of exposure to antipseudomonal β-lactam antibiotics in the critically ill and development of new resistance.
Teshome, B. F., Vouri, S. M., Hampton, N., Kollef, M. H., & Micek, S. T. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2201 · Cited by 190 · see citing works
Shortened courses of antibiotics for bacterial infections: A systematic review of randomized controlled trials.
Hanretty, A. M., & Gallagher, J. C. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2118 · Cited by 123 · see citing works
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082 · see citing works
Self-citation
Shorter versus longer courses of antibiotics for infection in hospitalized patients: A systematic review and meta-analysis.
Royer, S., DeMerle, K. M., Dickson, R. P., & Prescott, H. C. (2018) · Journal of Hospital Medicine · doi:10.12788/jhm.2905 · Cited by 94 · see citing works
Nasal methicillin-resistant staphylococcus aureus (MRSA) PCR testing reduces the duration of MRSA-targeted therapy in patients with suspected MRSA pneumonia.
Baby, N., Faust, A. C., Smith, T., Sheperd, L. A., Knoll, L., & Goodman, E. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02432-16 · Cited by 94 · see citing works
Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis.
Ehmann, L., Zoller, M., Minichmayr, I. K., Scharf, C., Huisinga, W., Zander, J., & Kloft, C. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.06.016 · Cited by 67 · see citing works
Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL
Paonessa, J. R., Shah, R. D., Pickens, C. I., Lizza, B. D., Donnelly, H. K., Malczynski, M., Qi, C., & Wunderink, R. G. (2019) · Chest · doi:10.1016/j.chest.2019.02.007 · Cited by 66 · see citing works
Outcomes associated with de-escalating therapy for methicillin-resistant Staphylococcus aureus in culture-negative nosocomial pneumonia.
Cowley, M. C., Ritchie, D. J., Hampton, N., Kollef, M. H., & Micek, S. T. (2019) · Chest · doi:10.1016/j.chest.2018.10.014 · Cited by 49 · see citing works
Development of anacardic acid-loaded zein nanoparticles: Physical chemical characterization, stability and antimicrobial improvement
Araujo, J. T. C. D., Martin-Pastor, M., Pérez, L., Pinazo, A., & Sousa, F. F. O. D. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115808 · Cited by 46 · see citing works
Effect of antibiotic discontinuation strategies on mortality and infectious complications in critically ill septic patients: A meta-analysis and trial sequential analysis.
Arulkumaran, N., Khpal, M., Tam, K., Baheerathan, A., Corredor, C., & Singer, M. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004267 · Cited by 36 · see citing works
Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
Collins, C. D., Brockhaus, K., Sim, T., Suneja, A., & Malani, A. N. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz129 · Cited by 25 · see citing works
Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case–control study
Torre-Cisneros, J., Natera, C., Mesa, F., Trikic, M., & Rodríguez-Baño, J. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3100-y · Cited by 20 · see citing works
Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI choosing wisely campaign
Furlan, L., Erba, L., Trombetta, L., Sacco, R., Colombo, G., Casazza, G., Solbiati, M., Montano, N., Marta, C., Sbrojavacca, R., et al. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1955-2 · Cited by 9 · see citing works
Optimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11 · see citing works

[Value of the clinical pulmonary infection score for the prognosis of ventilator-associated pneumonia].
Yang, G., & Wang, G. (2006) · PubMed · Cited by 3 · see citing works
Is it possible to reduce the incidence of ventilator-associated pneumonia (VAP) to zero?
Hasegawa, R., & Shime, N. (2014) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.21.9 · Cited by 1 · see citing works
Ventilator-associated pneumonia：VAPと ventilator-associated events：VAEサーベイランス
今井寛 (2013) · The Japanese Society of Intensive Care Medicine
The Incidence of VAP after VAP Bundle Intervention Among Patients with Mechanical Ventilation
Susmiarti, D., Harmayetty, H., & Dewi, Y. S. (2015) · Jurnal NERS · doi:10.20473/jn.v10i12015.138-146
Bundle of care decreased ventilator-associated events—implications for ventilator-associated pneumonia prevention
Neuville, M., Mourvillier, B., Bouadma, L., et al. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.02.72 · Cited by 12 · see citing works

Authors: Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., El Solh, A. A., Ewig, S., Fey, P. D., File, T. M., Restrepo, M. I., Roberts, J. A., Waterer, G. W., Cruse, P., Knight, S. L., & Brozek, J. L.
Affiliations: Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha
University of Connecticut (US)
Brigham and Women's Hospital (US)
Queen's University (CA)
University of California San Diego (US)
State University of New York (US)
University of Michigan (US)
Department of Critical Care Medicine, National Institutes of Health, Bethesda
Johns Hopkins University (US)
Bellvitge University Hospital (ES)
Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University at Buffalo, Veterans Affairs Western New York Healthcare System, New York
Augusta-Kranken-Anstalt (DE)
Nebraska Medical Center (US)
Summa Health System (US)
The University of Texas at San Antonio Health Science Center (US)
The University of Queensland (AU)
The University of Western Australia (AU)
National Jewish Health (US)
Department of Clinical Epidemiology and Biostatistics and Department of Medicine, McMaster University, Hamilton, Ontario, Canada
ORCID: Metersky, Mark L.
Klompas, Michael
Muscedere, John
Sweeney, Daniel A.
Palmer, Lucy B.
Napolitano, Lena M.
Carratalà, Jordi
Fey, Paul D.
File, Thomas M.
Restrepo, Marcos I.
Roberts, Jason A.
Waterer, Grant W.
Cruse, Peggy
Knight, Shandra L.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2016-07-14
Volume: 63
Issue: 5
Pages: e61-e111
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1093/cid/ciw353
PMC: PMC4981759
OpenAlex: W2473016454
Semantic Scholar: cc67f6fcef3f691050f3a9c18034f837b8e242f9
Cited by: 3,892
References: 363
Citations by year: 2026: 333 · 2025: 355 · 2024: 367 · 2023: 477 · 2022: 493 · 2021: 448 · 2020: 415 · 2019: 351 · 2018: 328 · 2017: 263 · 2016: 50 · 2015: 1 · 2014: 2
FWCI: 300.13
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Clinical Infectious Diseases (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion, cc-by)
HighWire Press Open Archive (submittedVersion)
RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by)
Funders: National Heart, Lung, and Blood Institute
NIH
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Keywords: nosocomial pneumonia, ventilator-associated pneumonia, pneumonia diagnosis, pneumonia treatment, critically ill patients, hospitalized adults
MeSH terms: Adult, Anti-Bacterial Agents, Bacteriological Techniques, Cross Infection, Humans, United States, Pneumonia, Bacterial, Drug Resistance, Multiple, Bacterial, Pneumonia, Ventilator-Associated

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks